FDAClass IFebruary 5, 2014

Soliris recall: Particulate Matter

Soliris (eculizumab) Concentrated Solution for Intravenous Infusion Only, 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial, Rx only, Manufactured by…

Why was Soliris recalled?

Presence of Particulate Matter: Failed the appearance test for the presence of visible particles.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot #: 10001-1, Exp 07/14; 10010A, Exp 10/15

Product
Soliris (eculizumab) Concentrated Solution for Intravenous Infusion Only, 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial, Rx only, Manufactured by…
Recalling firm
Alexion Pharmaceuticals, Inc.
Quantity
21,661 vials
Distribution
Nationwide, Puerto Rico, Jamaica, and Grenada.
Recall date
February 5, 2014
Classification
Class I
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls